Catalogo dei prodotti della ricerca

PALANO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.172
EU - Europa 306
AS - Asia 195
AF - Africa 21
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.706
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.166
IT - Italia 102
SG - Singapore 82
DE - Germania 71
IN - India 59
CN - Cina 48
FI - Finlandia 28
SE - Svezia 27
IE - Irlanda 26
TG - Togo 19
UA - Ucraina 13
BG - Bulgaria 9
RU - Federazione Russa 9
AR - Argentina 8
RO - Romania 7
GB - Regno Unito 5
CA - Canada 4
FR - Francia 4
ID - Indonesia 4
RS - Serbia 4
CL - Cile 2
MX - Messico 2
ZA - Sudafrica 2
BR - Brasile 1
CY - Cipro 1
EU - Europa 1
NL - Olanda 1
TR - Turchia 1
Totale 1.706
Salva come PNG Salva come JPEG
Città #
Fairfield 196
Ashburn 107
Woodbridge 100
Seattle 98
Houston 78
Cambridge 71
Wilmington 68
Singapore 65
Chandler 64
Santa Clara 44
Princeton 31
Rome 31
Ann Arbor 27
San Paolo di Civitate 26
Beijing 25
Plano 23
Dearborn 21
Lawrence 21
Lomé 19
Dublin 13
Boston 12
Helsinki 12
Millbury 11
Andover 10
Sofia 9
San Diego 8
Federal 7
Boardman 6
Falls Church 6
Norwalk 6
Falkenstein 5
Florence 5
Jacksonville 5
Albano Laziale 4
Fremont 4
Hefei 4
Jakarta 4
Moscow 4
New York 4
Menlo Park 3
Milan 3
Buffalo 2
Cantalupo in Sabina 2
Chongqing 2
Frankfurt am Main 2
Norwich 2
Ottawa 2
Pune 2
Quartu Sant'Elena 2
Romainville 2
Tappahannock 2
Toronto 2
Xian 2
Basking Ridge 1
Buenos Aires 1
Bühl 1
Chengdu 1
Des Moines 1
Elista 1
Fountain Valley 1
Galati 1
Genova 1
Guangzhou 1
Hanover 1
Hyderabad 1
Indiana 1
Istanbul 1
Jinan 1
Kunming 1
Leipzig 1
London 1
Los Angeles 1
Mexico City 1
Muizenberg 1
Munich 1
Nanchang 1
Nicosia 1
Paris 1
Philadelphia 1
Phoenix 1
Prescot 1
Provo 1
Silverton 1
Targu Jiu 1
Torino 1
Vidin 1
Washington 1
Wenzhou 1
Zhengzhou 1
Totale 1.320
Salva come PNG Salva come JPEG
Nome #
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy 109
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 93
Antihypertensive Therapy in Diabetes: The Legacy Effect and RAAS Blockade 82
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? 81
Evaluation of Systolic Properties in Hypertensive Patients With Different Degrees of Diastolic Dysfunction and Normal Ejection Fraction 78
Fixed-combination therapies in hypertension management: Focus on enalapril/lercanidipine 73
The clinical relevance of dysfunctional HDL in patients with coronary artery disease: A 3-year follow-up study 73
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 73
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool 72
Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire 70
Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD 67
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials 63
Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator 63
The subcutaneous implantable cardioverter-defibrillator. Current trends in clinical practice between guidelines and technology progress 63
Hypertension and cardiovascular risk: The importance of a global approach to risk management in the light of current hypertension guidelines 62
Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring 62
Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study 61
Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator 61
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 60
Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. 59
Impact of hypertension on global cardiovascular risk stratification: analysis of a large cohort of outpatient population in Italy 58
Network meta-analysis of heart failure prevention by antihypertensive drugs - Reply 57
Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal disease 51
[The progression from hypertension to congestive heart failure]. 40
Antihypertensive Treatment and Development of Heart Failure in Hypertension A Bayesian Network Meta-analysis of Studies in Patients With Hypertension and High Cardiovascular Risk 38
Prevention of sudden cardiac death: focus on the subcutaneous implantable cardioverter-defibrillator 37
Prognostic implications of non-sustained VT morphology in high-risk patients with HCM 27
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 18
Assessing Atrial Fibrillation Substrates by P Wave Analysis. A Comprehensive Review 14
Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy 11
Totale 1.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020287 0 0 0 0 0 59 59 53 52 29 18 17
2020/2021139 11 19 4 9 3 10 4 12 11 27 20 9
2021/2022321 9 11 35 29 54 8 9 34 24 19 44 45
2022/2023271 49 81 13 19 21 22 5 16 26 3 9 7
2023/2024145 7 21 8 16 5 31 2 13 2 22 14 4
2024/2025157 2 28 26 14 56 31 0 0 0 0 0 0
Totale 1.776